NEW YORK, Dec. 17, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) investors who purchased Catalyst stock during the period from October 31, 2012 to October 18, 2013, inclusive, of the important December 24, 2013 lead plaintiff deadline.
To join the Catalyst class action, visit the firm's website at http://rosenlegal.com, or call Phillip Kim, Esq. or Jonathan Horne, Esq., toll-free, at 866-767-3653; you may also email email@example.com or firstname.lastname@example.org for information on the class action. The lawsuit filed by the firm is pending in the U.S. District Court for the Southern District of Florida.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.
The Complaint asserts violations of the federal securities laws against Catalyst and certain of its officers and directors for issuing materially false and misleading information about the Company. The Complaint asserts that Catalyst failed to disclose that one of its competitors has already been manufacturing a drug biologically equivalent to Firedapse – a drug Catalyst has claimed to be developing and marketing – and providing the drug to patients to treat Lambert-Eaton Myasthenic Syndrome free of charge, through a compassionate use program. The lawsuit asserts that the disclosure of this adverse information caused Catalyst's share price to fall, damaging investors.
If you wish to serve as lead plaintiff, you must move the Court no later than December 24, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Jonathan Horne, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at email@example.com or at firstname.lastname@example.org. You may also visit the firm's website at http://rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. Jonathan Horne, Esq. The Rosen Law Firm P.A. 275 Madison Avenue, 34th Floor New York, New York 10016 Tel: (212) 686-1060 Toll Free: 1-866--767-3653 Fax: (212) 202-3827 email@example.com firstname.lastname@example.org email@example.com www.rosenlegal.comSource: The Rosen Law Firm PA PC